Chronic inflammation appears to contribute to tumor progression by establishing a milieu conducive to development of different cancers at all three stages of tumor development: initiation, progression and metastasis, inducing the release of a variety of c
Here we will examine the major cytokines currently in use or under evaluation for cancer therapy: interferon alfa, IL-2, GM-CSF, and interleukin-12 (IL-12).
Dichloroacetate (DCA) committs "immortal" cancer cells to a natural death while leaving normal cells unharmed - but DCA is not patentable, so pharmaceutical companies have no incentive to begin clinical trials...
A presentation made at the 17th International Prostate Cancer Update Conference in Vail, Colorado, has shown noscapine to be effective against prostate cancer. Noscapine, a non-addictive derivative of opium, has been used worldwide since the 1950's as an
Green tea consumption is associated with reduced mortality due to all causes and due to cardiovascular disease but not with reduced mortality due to cancer.
Despite 15 years as a cancer doctor and researcher, I struggle several times each week to endure the hardest part of my job – walking into a patient's room to helplessly watch as cancer steals away their life and torments them and their loved ones...we
The conventional concept of tumor-host interactions is rooted in the realm of parasitology. A tumor invades an unsuspecting host, and in response to this assault, the host attempts to resist the advances of the tumor by calling on the armamentarium of the
Sample article titles: Confronting Death: Understanding how and why people approach death differently. The renewed search for natural products with cancer-fighting capabilities. Is It Time to Change the Design of Clinical Trials?